论文部分内容阅读
目前,干扰素(IFN)治疗丙型肝炎病毒(HCV)感染的疗效监测,需要重复静脉采血。本文旨在评价接受IFN治疗的慢性HCV感染患者,其血清与唾液标本中HCV存在的情况,了解唾液能否替代血液,用于监测IFN治疗慢性HCV感染的疗效。
Currently, the efficacy of interferon (IFN) in the treatment of Hepatitis C virus (HCV) infection is monitored by repeated venous blood sampling. This article aims to assess the presence of HCV in serum and saliva specimens of patients with chronic HCV infection who are treated with IFN to determine whether saliva can replace blood and to monitor the efficacy of IFN in the treatment of chronic HCV infection.